Comparison of cutaneous tolerance and efficacy of calcitriol 3 μg g⁻¹ointment and tacrolimus 0·3 mg g⁻¹ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial

Abstract

Both calcitriol 3 microg g(-1) and tacrolimus 0.3 mg g(-1) are safe and well-tolerated therapeutic agents in the treatment of psoriasis in sensitive areas. Tacrolimus demonstrated a more effective clinical outcome compared with calcitriol.